Business
Currency:SGD
2023/FY
Stock NameRevenueRatio
Oncology services81.03M96.70%
Cellular and gene therapy related products and services2.76M3.30%
Region
Currency:SGD
2023/FY
Stock NameRevenueRatio
Singapore78.8M94.04%
China and Hong Kong2.16M2.57%
Australia1.2M1.43%
New Zealand1.01M1.20%
United States of America549K0.66%
Vietnam82K0.10%
View all
